We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current HUMAW market cap is 325.81M. The company's latest EPS is USD -0.5362 and P/E is -20.44.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -24.62M | -26.18M | -26.58M | -29.5M | -30.23M |
| Net Income | -26M | -25.11M | -31.9M | -56.66M | -39.2M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.26M | 1.57M | 0 |
| Operating Income | -249k | -81.26M | -84.58M | -100.05M |
| Net Income | -233k | -26.48M | -11.97M | -110.78M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 149.39M | 128.22M | 161.47M | 138.28M | 114.76M |
| Total Liabilities | 112.39M | 114.68M | 135.31M | 166.57M | 178.49M |
| Total Equity | 36.99M | 13.55M | 26.15M | -28.29M | -63.72M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 101.26M | 286.53M | 204.3M | 128.22M |
| Total Liabilities | 2.1M | 164.36M | 87.37M | 114.68M |
| Total Equity | 5M | 122.17M | 116.93M | 13.55M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -54.25M | -73.31M | -27.35M | -48.64M | -71.55M |
| Investing | -23k | -173k | -391k | -575k | -1.51M |
| Financing | 4.84M | 4.51M | 62.8M | 62.33M | 63.18M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -245k | -81.19M | -71.13M | -73.31M |
| Investing | -100M | -8.22M | 4.85M | -173k |
| Financing | 101.34M | 266.98M | -1.45M | 4.51M |
| Market Cap | 325.81M |
| Price to Earnings Ratio | -20.44 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 28.15 |
| Price to Book Ratio | 167.14 |
| Dividend Yield | - |
| Shares Outstanding | 206.58M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.44 (24.44%) |
| Company Name | Humacyte Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.humacyte.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
